share_log

Janux Shares Are Trading Higher After It Announced Doses Selected for Its Phase 1b Expansion Trials Supported by Encouraging Efficacy and Safety Profile Observed in Phase 1a Dose.

Benzinga ·  Dec 3, 2024 05:33
Janux Shares Are Trading Higher After It Announced Doses Selected for Its Phase 1b Expansion Trials Supported by Encouraging Efficacy and Safety Profile Observed in Phase 1a Dose.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment